摘要
虽然最近的证据已经出现阿尔茨海默病(AD)和遗忘型轻度认知功能障碍(aMCI)患者显示区域脑发育异常和脑网络的拓扑变性,我们理解在AD和aMCI患者的大脑网络的拓扑结构影响白质纤维异常是仍然浅陋。在这项研究中,我们调查在AD和aMCI患者的区域容积畸变和全局异常。结果表明,一种广泛分布在灰质和白质萎缩的AD和aMCI组。特别是,AD患者和正常对照相比,aMCI与纤维长度长弱连接(NC)组,由各向异性分数(FA)评估。此外,所有三组的脑网络表现出显着的经济小世界特性。有趣的是,拓扑特征估计从二进制的大脑网络没有表现出显著的群体效应,说明在AD和aMCI保持最佳的拓扑结构具有正在退化的趋势。然而,在足总加权脑网络的AD和aMCI患者中,观察到显着较长的特征路径长度,提示功能性的全球一体化。此外,特征路径长度的异常与认知功能障碍的临床评分呈负相关。因此,结果表明,在加权脑网络的广告的拓扑改变引起的损失与长纤维长度的连通性。我们的研究结果提供了新的见解,在AD中的脑网络的改变,并可能表明脑网络指标的预测值作为生物标志物的疾病发展。
关键词: 阿尔茨海默氏病,遗忘型轻度认知功能障碍,脑组织,弥散张量成像,大脑网络结构,脑白质连通。
Current Alzheimer Research
Title:Disrupted Structural Brain Network in AD and aMCI: A Finding of Long Fiber Degeneration
Volume: 12 Issue: 6
Author(s): Rong Fang, Xiao-Xiao Yan, Zhi-Yuan Wu, Yu Sun, Qi-Hua Yin, Ying Wang, Hui-Dong Tang, Jun-Feng Sun, Fei Miao and Sheng-Di Chen
Affiliation:
关键词: 阿尔茨海默氏病,遗忘型轻度认知功能障碍,脑组织,弥散张量成像,大脑网络结构,脑白质连通。
摘要: Although recent evidence has emerged that Alzheimer’s disease (AD) and amnestic mild cognitive impairment (aMCI) patients show both regional brain abnormalities and topological degeneration in brain networks, our understanding of the effects of white matter fiber aberrations on brain network topology in AD and aMCI is still rudimentary. In this study, we investigated the regional volumetric aberrations and the global topological abnormalities in AD and aMCI patients. The results showed a widely distributed atrophy in both gray and white matters in the AD and aMCI groups. In particular, AD patients had weaker connectivity with long fiber length than aMCI and normal control (NC) groups, as assessed by fractional anisotropy (FA). Furthermore, the brain networks of all three groups exhibited prominent economical small-world properties. Interestingly, the topological characteristics estimated from binary brain networks showed no significant group effect, indicating a tendency of preserving an optimal topological architecture in AD and aMCI during degeneration. However, significantly longer characteristic path length was observed in the FA weighted brain networks of AD and aMCI patients, suggesting dysfunctional global integration. Moreover, the abnormality of the characteristic path length was negatively correlated with the clinical ratings of cognitive impairment. Thus, the results therefore suggested that the topological alterations in weighted brain networks of AD are induced by the loss of connectivity with long fiber lengths. Our findings provide new insights into the alterations of the brain network in AD and may indicate the predictive value of the network metrics as biomarkers of disease development.
Export Options
About this article
Cite this article as:
Rong Fang, Xiao-Xiao Yan, Zhi-Yuan Wu, Yu Sun, Qi-Hua Yin, Ying Wang, Hui-Dong Tang, Jun-Feng Sun, Fei Miao and Sheng-Di Chen , Disrupted Structural Brain Network in AD and aMCI: A Finding of Long Fiber Degeneration, Current Alzheimer Research 2015; 12 (6) . https://dx.doi.org/10.2174/1567205012666150530201349
DOI https://dx.doi.org/10.2174/1567205012666150530201349 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
Call for Papers in Thematic Issues
New Advances in the Prevention, Diagnosis, Treatment, and Rehabilitation of Alzheimer's Disease
Aims and Scope: Introduction: Alzheimer's disease (AD) poses a significant global health challenge, with an increasing prevalence that demands concerted efforts to advance our understanding and strategies for prevention, diagnosis, treatment, and rehabilitation. This thematic issue aims to bring together cutting-edge research and innovative approaches from multidisciplinary perspectives to address ...read more
Diagnostic and therapeutic biomarkers of dementia
Dementia affects 18 million people worldwide. Dementia is a syndrome of symptoms caused by brain disease, usually chronic or progressive, clinically characterized by multiple impairments of higher cortical functions such as memory, thinking, orientation, and learning. In addition, in the course of dementia, cognitive deficits are observed, which often hinder ...read more
Early nutritional intervention and physical activity in the prevention of Alzheimer's disease and other dementias
The aim is to broaden the knowledge about the impact of the consumption of food ingredients, diet ingredients, methods of processing of food raw materials as well as the impact of composing of diets on the possibility of preventing Alzheimer's disease and other types of dementia at each stage of ...read more
Enhancing Alzheimer's Disease Diagnosis and Treatment Efficacy Prediction with Explainable AI, Radiomics, Biomarkers, and Multimodal Neuroimaging
The thematic issue, Enhancing Alzheimer's Disease Diagnosis and Treatment Efficacy Prediction with Explainable AI, Radiomics, Biomarkers, and Multimodal Neuroimaging, aims to bridge the gap between advanced computational techniques and clinical practice in Alzheimer’s disease research. Alzheimer’s disease poses significant challenges in early diagnosis, disease progression monitoring, and predicting treatment efficacy. ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Opioids and the Blood-Brain Barrier: A Dynamic Interaction with Consequences on Drug Disposition in Brain
Current Neuropharmacology Development and Optimization of Controlled Porosity Osmotic Tablets of Lamotrigine Solid Dispersion
Recent Patents on Drug Delivery & Formulation Cellular Membranes and Lipid-Binding Domains as Attractive Targets for Drug Development
Current Drug Targets Structurally Unprecedented Metabolites from Marine Sponges
Current Organic Chemistry Role of the Endocannabinoid System in the Neuroendocrine Responses to Inflammation
Current Pharmaceutical Design Cardiac Biomarkers in Stroke, Alzheimer’s Disease, and Other Dementia. Are They of Use? A Brief Overview of Data from Recent Investigations
CNS & Neurological Disorders - Drug Targets Novel Pyrimidine based Semicarbazones: Confirmation of Four Binding Site Pharmacophoric Model Hypothesis for Antiepileptic Activity
Central Nervous System Agents in Medicinal Chemistry Monocytes as Carriers of Magnetic Nanoparticles for Tracking Inflammation in the Epileptic Rat Brain
Current Drug Delivery Molecular Mechanisms of Cardiac Voltage-Gated Potassium Channelopathies
Current Pharmaceutical Design Antiepileptic Drug Monotherapy: The Initial Approach in Epilepsy Management
Current Neuropharmacology Gene Therapy for Angelman Syndrome: Contemporary Approaches and Future Endeavors
Current Gene Therapy Zebrafish as an Animal Model to Study Epileptic Seizures and Epileptic Syndromes
Current Psychopharmacology Cytochrome P450s: Mechanisms and Biological Implications in Drug Metabolism and its Interaction with Oxidative Stress
Current Drug Metabolism Long-Term Outcome of Infants Born Late Preterm
Current Pediatric Reviews Integrated Application of Enhanced Replacement Method and Ensemble Learning for the Prediction of BCRP/ABCG2 Substrates
Current Bioinformatics Mitochondrial Respiratory Complex I: Structure, Function and Implication in Human Diseases
Current Medicinal Chemistry Old Strategies and New Perspectives in Modulating the Endocannabinoid System
Current Bioactive Compounds mTOR: A Novel Therapeutic Target for Diseases of Multiple Systems
Current Drug Targets Melatonin in the Biliary Tract and Liver: Health Implications
Current Pharmaceutical Design Pharmacogenetics of Obesity Drug Therapy
Current Molecular Medicine